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AbstrACt
Introduction Over 160 000 people with severe hip or 
knee pain caused by osteoarthritis undergo total hip 
(THR) or knee replacement (TKR) surgery each year 
in the UK within the National Health Service (NHS), 
and this number is expected to increase. Innovative 
approaches to evaluating surgical outcomes will be 
needed to respond to the increasing burden of joint 
replacement surgery. The Sensor Platform for Healthcare 
in a Residential Environment, Interdisciplinary Research 
Collaboration (SPHERE-IRC) have developed a system of 
sensors that can monitor the health-related behaviours 
of people living at home. The system includes sensors 
for the home environment (measuring temperature, 
humidity, room occupancy, water and electricity usage), 
a wristband body-worn activity monitor and silhouette 
(body outline) sensors. The aim of HEmiSPHERE (Hip 
and knEe study of a Sensor Platform of HEalthcare 
in a Residential Environment) is to (1) determine the 
accuracy and feasibility of the sensory data as it 
compares with conventional assessment of health 
outcomes after surgery using patient self-reported 
questionnaires, and (2) to explore how the SPHERE 
system is useful for everyday clinical decision-making.
Methods and analysis A feasibility study recruiting 
and installing the SPHERE system in the homes of up 
to 30 NHS adult patients as they undergo a THR or TKR. 
Through a mixed-methods design, the SPHERE system 
will monitor and record continuous measurements of daily 
behaviour. Main outcomes will assess the relationships 
between environmental, behavioural and movement data 
and the parameters of interest from the standard clinical 
assessments measuring patient outcomes over time. Patient 
interviews and focus groups with consultant orthopaedic 
surgeons will provide in-depth understanding of the 
acceptability, feasibility and accuracy of the data.
Ethics and dissemination We aim to disseminate the 
findings through regional talks and seminars, international 
conferences and peer-reviewed journals and social media.
IntroduCtIon  
Total hip and knee replacements (THR and 
TKR) are two of the most common elective 
surgical procedures carried out in the UK.1 
Recent data from the National Joint Registry 
for England, Wales, Northern Ireland and 
the Isle of Man show the number of primary 
total joint replacement operations is 
increasing with 224 470 procedures (83 886 
primary THR and 94 023 primary TKR) 
performed in the 12 months to 31 March 
2016.2 Trends in recent data show a median 
age for patients undergoing a primary TKR 
and THR of 70 and 69 years, respectively, 
and osteoarthritis as the most common 
reason for surgery accounting for over 90% 
of THRs and TKRs.2 
With a growing, more active older popula-
tion in the UK, the volume of THRs and TKRs 
in the UK will continue to increase.3 Changing 
demographics of age, gender and Body Mass 
Index (BMI) and recent data indicating an 
strengths and limitations of this study
 ► This is the first study to install and test low-powered 
home sensing technology in the homes of patients 
undergoing joint replacement.
 ► Assessment of daily continuous information on 
patient activity in their natural setting could allow 
clinicians to better understand recovery, direct reha-
bilitation and tailor interventions.
 ► A mixed-methods approach to the design, evaluating 
sensor data against routinely used patient-report-
ed outcome measures and qualitative information 
about the patient’s journey strengthens the valida-
tion process.
 ► The present study sample is small and the patients 
drawn from a relatively narrow age range, which 
limits generalisability to patient populations in other 
settings.
 ► Although a small sample, detailed information and 
data analytics of each case, and exploring the per-
ceived value of the sensor data among clinicians will 
enable deeper exploration about the mechanisms by 
which this could be integrated within current clinical 
systems.
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increasing number of younger patients undergoing THR 
suggest functional demands expected of these operations 
will change and thus assessment of outcomes may need 
to evolve.4 5
Patient-reported outcome measures (ProMs)
PROMs are standardised, validated questionnaires 
completed by patients to measure functional status 
and well-being6 and are now widely used as part of the 
national PROMs programme set by National Health 
Service (NHS) England.7 PROMs are thus widely used in 
research and clinical settings as they are considered easy 
to use, inexpensive and time efficient.8
Assessment of health outcomes after THR and TKR 
focus mainly on four domains: function, mobility, pain 
and quality of life. Although assessment of outcomes 
after surgery provides evidence of effect, PROMs are 
subjective and, by definition, are easily influenced by 
socioeconomic or psychological factors and dominated 
by pain.9 Furthermore, assessment measures specific 
to the field of orthopaedics, such as the commonly 
used disease-specific Western Ontario and McMaster 
Universities Osteoarthritis Index, validated for use with 
patients undergoing joint replacement, suffer (as with 
many orthopaedic PROMs) from a ceiling effect as it has 
a limited maximum value that is reached by a substantial 
proportion of patients who report no pain or functional 
limitations after surgery.10 Bolink and colleagues high-
light that a consequence of this ceiling effect is that the 
true extent of patient’s postoperative functional avail-
abilities cannot be determined, and further highlight 
the importance of investigating relative changes rather 
than absolute changes and to consider patients with 
high and low functions separately.8 Given the limita-
tions of PROMs, research needs to shift towards consid-
ering other methods of assessing functional outcomes 
after surgery.8
Home Health Monitoring and 3millionlives (3ML)
In the UK, the government has been keen to promote 
telehealth as a way for a pressured NHS to cope with an 
ageing population with multiple long-term health condi-
tions. The Whole System Demonstrator programme11 12 
was designed to demonstrate how system change along-
side assistive technology could achieve a better quality 
of care for people living with long-term conditions 
and social care needs. Monitoring vital health signs 
remotely using telehealth was seen to enable health 
professionals to intervene at the right time to prevent 
exacerbation. Telehealth thus allows people to remain 
independent in their homes for longer and provides the 
choice and control of healthcare services to the patient. 
The ‘3millionlives’ (3ML) initiative was a commitment 
between the Department of Health (DoH) in England 
and the UK telehealth and telecare industry in 201213 
to enhance the lives of 3 million people over the next 5 
years by accelerating the roll-out of telehealth and tele-
care in the NHS and social care. In turn, 3ML would 
reduce the burden of acute hospital inpatient care and 
deliver more cost-effective services as part of a modern 
model of integrated care. The programme rolled out 
through a wide range of delivery modes and mecha-
nisms from creative innovation, new housing solutions, 
integration of services, interoperable systems, smart 
cities and mobile technologies (digital patient records 
and data protection).
technology Enabled Care services (tECs) (nHs England) 
Evidence database
The TECS programme14 was born out of the 3ML initia-
tive. The programme has resulted in mixed findings15; 
however, a positive outcome was the development of a 
large and complex evidence database. TECS are studies 
of complex interventions involving people, processes 
and technology, based on a range of methodologies; 
therefore, results are influenced by each of those 
elements. In some contexts, there are mixed messages 
on the clinical and cost-effectiveness of some of these 
TECS.
Three key studies from the database highlight the 
empirical evidence around the use of smart wearable 
body sensors for patient self-assessment and moni-
toring,16 the impact of digital engagement on the quality 
of life of older people17 and the technical challenges of 
developing high-quality biometric signals from unsuper-
vised patients at home.18 Studies investigating wearable 
body sensors such as connected devices, trackers, tele-
monitoring, wireless technology and real-time home 
tracking devices demonstrate that smart wearable sensors 
are effective and reliable for preventative interventions 
in many different facets of medicine such as cardiopul-
monary, vascular, endocrine, neurological function and 
rehabilitation medicine.16 Such sensors have also been 
shown to be accurate and useful for perioperative and 
rehabilitation medicine.
Many individuals with chronic disease could benefit 
from having constant remote monitoring, and the best 
way to monitor a patient is through understanding their 
interactions with their environment and daily activities. 
Giving the patient the opportunity to leave the hospital 
or healthcare environment but continuing to monitor 
them allows for a more authentic representation and 
a more accurate assessment of physiological data. For 
patients who undergo THR and TKR, the ability to reli-
ably monitor away from the hospital could decrease the 
healthcare and cost burden associated with inpatient 
length of stay and outpatient follow-up.
There is consensus within the literature that incor-
porating smart wearable sensors into routine care of 
patients could augment physician–patient relationships, 
increase the autonomy and involvement of patients with 
their healthcare and provide for novel remote moni-
toring techniques, which could revolutionise healthcare 
and management. The future challenges lie within inte-
grating telehealth within older populations17 and applying 
predictive analytics and data mining for enhancing 
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clinical decision support,18 which HEmiSPHERE, in part, 
aims to address.
sensor Platform of Healthcare in a residential Environment—
sPHErE
The Sensor Platform of Healthcare in a Residential 
Environment Interdisciplinary Research Collaboration 
(SPHERE-IRC) at the University of Bristol, Faculty of 
Engineering, have developed innovative technology 
comprising a group of low-power sensors that can 
measure information continuously about the home (eg, 
temperature, energy consumption etc) as well as informa-
tion about people in the home (eg, location, how active 
they are, extent of movement) and their health-related 
behaviours. A key element to the SPHERE sensor system 
is that data are time-stamped and collected within their 
natural home environment.
It is proposed that this ‘real time’ continuous data 
collected by SPHERE sensors could potentially, in 
contrast to conventional methods of assessment of patient 
change and recovery processes through the collection of 
PROMs, capture a more global picture of the patient as 
they undergo a THR or TKR. The SPHERE 100 Homes 
study has been designed and is being conducted by 
SPHERE-IRC to try out and test this system in different 
populations, generate data and explore whether the 
system works.
Hip and KnEe study of a sensor Platform of Healthcare in a 
residential Environment (HEmisPHErE)
The present HEmiSPHERE study is embedded within the 
SPHERE 100 Homes study. The aim of HEmiSPHERE is to 
understand whether clinically useful information can be 
obtained from the technology enabled service in a cohort 
of orthopaedic patients undergoing elective surgery 
(THR or TKR). Understanding how these data can help 
shape future healthcare from the perspectives of the end 
users (the patient and the clinician) and determining 
whether this form of telehealth enables or constrains clin-
ical decision-making also remains the primary purpose of 
this research study.
Specifically, this project has four main objectives:
a. To determine if the raw sensor data obtained from 
the SPHERE system can be processed to translate into 
meaningful data for the clinician.
b. To understand how the information provided by the 
SPHERE system enables, shapes or constrains clinical 
decision-making from the health professionals’ per-
spective and explore whether the SPHERE system is 
feasible and acceptable through the perspectives of 
patients’ undergoing elective surgery (THR or TKR).
c. To assess whether data from the SPHERE system pro-
vide a comparable measure of patient function and 
mobility than routinely collected standardised patient 
measures of PROMs.
d. To determine factors that facilitate or hinder the instal-
lation of the SPHERE system.
MEtHods And AnALysEs
study design
This feasibility study will adopt a concurrent mixed meth-
odology approach to understand how clinicians could 
use the SPHERE system in their everyday clinical deci-
sion-making.19 The quantitative approach will consist 
of comparing and contrasting data collected from stan-
dardised PROMs to that collected from the SPHERE 
sensors installed within patients’ homes. In parallel, the 
study will qualitatively explore patients’ experiences with 
the technology through in-depth interviews and explore 
the clinical value of the data through focus groups with 
health professionals. Bringing together information 
from both these sources will offer a more detailed under-
standing of whether the information collected by this 
novel technology could potentially improve healthcare 
delivery (see figure 1).
study setting
Installation of the SPHERE sensors will take place in the 
homes of NHS orthopaedic patients from one region of 
Bristol, UK. Interviews will be held within the patients’ 
homes. Focus groups with health professionals will be 
held within the Trust they are employed within.
Participants
Patient participants.
Inclusion criteria
 ► Patients aged 18 years and over.
 ► Patients referred for a THR or TKR.
 ► Patients able to read and understand English.
Exclusion criteria
 ► Lack of capacity to consent.
 ► Patients where a child (under 16 years) resides in 
their home.
Household participants
The study involves installation of the SPHERE system 
(sensors) within the patient’s house; therefore, all partic-
ipants residing within the household (family members or 
other key significant others) will become ‘participants’ in 
order that the SPHERE sensors are able to identify and 
differentiate the patient from the other key significant 
others. These participants will be referred to as house-
hold members and will each individually provide consent.
Health professional participants
We will recruit a convenience sample of orthopaedic 
surgeons employed within one NHS trust in Bristol, who 
perform joint replacement operations to participate in 
the focus groups. The focus group will be held approx-
imately 6 to 9 months after the first patient is recruited.
sample size
This is an exploratory study and therefore numbers 
of participants are chosen on pragmatic grounds and 
based on the experiences of the pilot installations from 
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the SPHERE 100 Homes study. We will include as many 
eligible participants as possible. For individual outcome 
data collection, we aim to allow for up to 30 participants 
undergoing a THR/TKR to be recruited.
Up to 30 patients will have the SPHERE system installed 
within their home and will each participate in the three 
forms of data collection, that is, questionnaires, inter-
views and collection of SPHERE sensor data, as depicted 
in figure 2. Each participant will complete two interviews 
and therefore up to 60 interviews may be conducted. 
Patients may be identified during the study as unsuitable 
for varying reasons (eg, unsuitable house, health compli-
cations affecting waiting time for surgery). Based on 
previous studies, we would expect to approach up to 100 
patients to achieve a sample size of 30.
data collection
Qualitative strand
Interviews
Pre-surgery, the purpose of the in-depth interview is to 
provide a baseline understanding about the patients’ 
general attitude to health technology and current 
usage of existing health technology in their home, for 
example, use of home blood pressure monitor and use 
of health mobile apps. This is a conventional exploratory 
qualitative analysis. Post-surgery, qualitative analysis will 
take a more directed approach so that findings can be 
triangulated with information provided by the PROMs 
and from the sensors. The purpose of triangulation is not 
necessarily to cross-validate data but to capture different 
dimensions of the same phenomenon.20 Strength of 
qualitative research is the benefit of induction, where 
the unexpected is discovered through interpreting the 
data.21 This is a process whereby you move forward 
the claims about the observed (which we will get from 
the SPHERE sensors and the summative data from the 
PROMs) to the unobserved. Qualitative research is 
concerned with generating ‘credible’ and ‘trustworthy’ 
data and analysis, involves interpretation and induction/
abduction, the key benefits of combining this source 
with that of quantitative PROMs and continuous sensory 
data provide a stronger platform for demonstrating the 
robustness of our interpretation of the data, and that our 
reasoning is credible.
Questions will incorporate open-ended techniques (eg, 
‘can you tell me about’ or ‘talk me through’) and the use 
of probes (eg, can you tell me more about that?). During 
the interview, the researcher will use a topic guide devel-
oped in collaboration with the research programme’s 
Public and Patient Involvement group and based on 
existing literature and theoretical underpinnings for 
living with home monitoring technology. The topic guide 
will follow the structure outlined in boxes 1 and 2. Topics 
will include current use of health technology within the 
home, expectations of surgery in relation to mobility and 
function, and experiences of living with the SPHERE 
system. The topic guide will be refined as data collection 
progresses and will be piloted in the first three to four 
interviews.
Focus groups
The purpose of the focus group is to explore, using a topic 
guide (see box 3), health professionals’ views and expe-
riences of the two types of data provided by the PROMs 
and the SPHERE sensors. HEmiSPHERE is a study that 
involves iterative processes, where health professionals 
will compare both forms of data, which will help to inform 
and refine further how the SPHERE system data can be 
Figure 1 Recruitment and consent process. PROM, patient-reported outcome measure; SPHERE, Sensor Platform of 
Healthcare in a Residential Environment.
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Figure 2 Study flow chart for patients. SPHERE, Sensor Platform of Healthcare in a Residential Environment.
box 1 topic guide—preoperative (patient)
 ► Case history to referral for surgery.
 ► Household constitution.
 ► Experience of health technology (home, wearable, apps).
 ► Current experience and future expectations of mobility and 
function.
 ► Preparations in the household for surgery.
box 2 topic guide—postoperative (patient)
 ► Experience of living with SPHERE technology.
 ► Relate data from individual PROM assessments within the questions.
 ► Ask about the adequacy of information received about SPHERE 
technology.
 ► Explore how initial expectations of living with the SPHERE technolo-
gy compares with those after surgery.
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transformed and provide anything useful beyond more 
conventional assessments of PROMs.
Quantitative strand
Patient-reported outcome measures
Baseline and follow-up data
The baseline questionnaire will include a collection of 
basic demographic information (marital status, occu-
pation, ethnicity, education and age) and a series of 
self-reported outcome measures to assess general health, 
quality of life, pain and functional mobility specific to 
the hip or knee and psychological status. The Hospital 
Anxiety and Depression Scale22 23 is a 14-item self-rating 
scale commonly used by doctors (and other health 
professionals) to determine the levels of anxiety and 
depression that a patient is experiencing. The EuroQol 
scale24 25 (EQ-5D-5L) is a quality-of-life instrument that 
comprises five dimensions (mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression) and 
a visual analogue scale for respondents to self-rate their 
health state. The Short Form 1226 27 (SF-12) is a generic 
measure to provide measurement of mental and physical 
functioning and overall health-related quality of life. The 
combination of the EQ-5D-5L and the SF-12 provides rela-
tively broad coverage of important health domains and 
scores for various purposes. The Pittsburgh Sleep Quality 
Index is a 19-item measure to assess sleep quality.28
Hip or knee pain and functional mobility will be 
measured using the Oxford Hip Score29 or Oxford Knee 
Score30. These measures are joint-specific 12-item ques-
tionnaires asking patients a series of questions that allow 
them to rate their level of pain and aspects for functional 
ability following surgery. The Knee Injury and Osteoar-
thritis Outcome Score (KOOS) and the Hip disability and 
Osteoarthritis Outcome Scores31 32 (HOOS) assess pain, 
other symptoms, function in daily living, function in sport 
and recreation, and hip-related or knee-related quality of 
life. The HOOS and KOOS are used to assess the patient’s 
opinion about their hip or knee and associated problems. 
We will be using the quality-of-life subscale within these 
measures.
The procedure and assessment times to measure these 
outcomes at baseline and subsequent time points are 
shown in table 1. Follow-up calls will start 4–9 days after 
discharge from hospital as outlined in table 1. In the event 
box 3 topic guide—postoperative (health professional)
 ► Stimulus-based discussion of the two data sources (PROMs and 
output of the SPHERE sensors).
 ► Transforming the data.
 ► Relevance of each sources to clinical decision-making.
 ► Compare the two data sources on accuracy, reliability and 
usefulness.
Table 1 Baseline and follow-up data collection time points
Time point Outcomes measured Tools
Clinical identification Baseline demographic information Clinical inclusion eligibility criteria
First telephone eligibility 
screening—preoperative
Confirm baseline demographic information, home fabric 
and eligibility
Telephone screening eligibility 
questionnaire
Visit A—preoperative, self-
completion
HrQoL, function status, pain, anxiety and depression, 
patient self-rating of hip or knee function
EQ-5D-5L, SF 12, HADS, OHS or 
OKS, HOOS/KOOS (QoL subscale)
Visit C—preoperative interview Questions relating to history to referral for surgery, 
household constitution, experience of home health 
technology, household preparation and constitution, 
expectations of mobility and function
Topic guide box 1
First telephone follow-up 
(4–9 days after hospital 
discharge)
Baseline demographic information, HrQoL, function 
status, pain, anxiety and depression, patient self-rating of 
hip or knee function, sleep routines/habits
EQ-5D-5L, SF-12, HADS, OHS or 
OKS, HOOS/KOOS (QoL subscale), 
PSQI
Second telephone follow-up 
(6/52)
Baseline demographic information, HrQoL, function 
status, pain, anxiety and depression patient self-rating of 
hip or knee function, sleep routines/habits
EQ-5D-5L, SF-12, HADS, OHS or 
OKS, HOOS/KOOS (QoL subscale), 
PSQI
Third telephone follow-up 
(12/52)
Baseline demographic information, HrQoL, SF-12, pain, 
HADS, patient self-rating of hip or knee function HADS, 
patient self-rating of hip or knee function, sleep routines/
habits
EQ-5D-5L, SF-12, HADS, OHS or 
OKS, HOOS/KOOS (QoL subscale), 
PSQI
Visit D—2-week postoperative 
interview
Questions relating to experience of living with SPHERE 
technology relating to PROMs
Topic guide box 2
6–9 month postoperative health 
professional focus group
Questions relating to the usability of SPHERE technology 
data compared with PROMs
Topic guide box 3
EQ-5D-5L, EuroQol 5D-5L; HADS, Hospital Anxiety and Depression Scale; HOOS/KOOS, Hip/Knee Dysfunction Osteoarthritis Outcome 
Score; HrQoL, health-related quality of life; OHS, Oxford Hip Score; OKS, Oxford Knee Score; PROM, patient-reported outcome measure; 
PSQI, Pittsburgh Sleep Quality Index; SF-12, Short Form 12; SPHERE, Sensor Platform of Healthcare in a Residential Environment. 
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of delays in patients being discharged from hospital, the 
study will adapt and build in flexibility on an individual 
basis.
SPHERE sensor system
The University of Bristol’s SPHERE project will provide 
equipment and analytical means to determine the 
person’s physiological envelope classified by activity types 
and levels. The study involves participants living with the 
SPHERE sensor system comprising sensors for the home 
environment (measuring temperature, humidity, room 
occupancy, water, electricity usage), a wristband body-
worn activity monitor and silhouette sensors.
Sensor data
This data collection happens continuously unless the 
participant uses the SPHERE Genie (described below) to 
turn off the system.
Environmental sensors
These small boxes (about the size of a fire alarm) include 
room presence sensors (as used by security alarms), 
humidity, temperature, water and flow metres. Small 
sensors will be plugged to some appliances (kettle, micro-
wave and fridge) to measure electricity use.
Wearable devices
The patient participant will be asked to wear a wristband; 
a research-quality accelerometer designed by the Univer-
sity of Bristol SPHERE team, tuned in to both hardware 
(physical electronics) and software (the programs and 
other operating information used by a computer). Inside 
the house, these sensors help the SPHERE system to 
measure movement, including the room the participant 
is in. Outside the home, they do not track the participant 
but only whether the participant is active or not.
Motion-analysis sensors
Two or three areas of the house will be equipped with 
a small motion-analysis sensor and an associated small 
computer (the size of a paperback book). There will be 
no motion-analysis sensors in the bathroom or bedrooms. 
The motion-analysis sensors do not record video; they 
capture features such as the position, orientation and 
silhouette (body outline) of any person in view of the 
sensor.
SPHERE Genie
The SPHERE Genie is the participant control panel that 
allows the participant to control the SPHERE system. 
Participants can delete data up to 24 hours earlier or 
pause the system and allows the participant to contact 
the SPHERE team. Frequency of deletion of data will be 
logged for monitoring purposes in order to address the 
magnitude of deletion of data. The SPHERE team will 
respond to the queries within a working day. The SPHERE 
team and the participant will communicate through the 
Genie using the participants email address or mobile tele-
phone number.
Activity data
Participants will be requested to allow information to be 
collected about their activities of daily living detected by 
the wrist-worn and environment sensors. These data will be 
captured in the form of silhouette motion analysis tuned 
into the requirements of orthopaedic clinicians where 
possible, at the same time as the periodic assessment of 
PROMs. These data will be collected for the entire dura-
tion of study participation as outlined in figure 1. The 
main outcome of the study is to compare this continuous 
activity data with data that are routinely collected from 
standardised PROMs when a patient undergoes a THR or 
TKR. This process will be iterative in that clinicians will 
be presented with data visualisations that the SPHERE 
sensor system currently produces, they will feedback with 
developing concepts and refine requirements. Therefore, 
the relationship investigated will be between the patients’ 
level of activity and function and how this changes over 
time and the various factors important for optimum 
recovery. How the SPHERE sensory system improves 
understanding of that relationship will be investigated.
Activity monitoring
The wearable wrist-worn device is designed to be mini-
mally intrusive. The wearable device measures three-axis 
acceleration to an accuracy of 32 milli-g (approximately 
0.3 m/s2). The indoor position measurement with 
the wearable device is to an accuracy of around 5 m 
(depending on room layout). The size of the sensor is no 
larger than an average watch.
The devices communicate encrypted data using 
commercial low-power wireless protocols. Each patient’s 
house will be equipped with two or three wireless access 
points for use with the SPHERE box, powered by stan-
dard mains-driven domestic USB power supplies. These 
have only transient physical contact with patients (for 
device re-charging); this hardware is off the shelf and 
CE-marked for domestic use.
The SPHERE devices, apart from communicating over 
Bluetooth, also communicates over the University of Bris-
tol’s own Wi-Fi network (we provide a separate router that 
operates at 5 GHz frequency, instead of 2.4 GHz, which is 
most common for home networks). The SPHERE team 
will not use the participant's home broadband; instead, 
we use LTE routers to send diagnostic information over 
the 3G/4G network. This is only for maintenance tasks 
such as checking that the sensors are running and battery 
levels. Dynamic channel changing will be used to avoid 
interference with home networks.
outcomes
Quantitative outcomes will be assessed with data metrics 
of the SPHERE system (measured continuously) and with 
the PROMs questionnaires (completed at specific time 
points before and after surgery). Individual quantitative 
changes will be interpreted by comparison with qualita-
tive interview and focus group data. These will be in the 
form of reported associations between these two types of 
copyright.
 o
n
 N
ovem
ber 15, 2019 at University of W
orcester. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-021862 on 28 July 2018. Downloaded from 
8 Grant S, et al. BMJ Open 2018;8:e021862. doi:10.1136/bmjopen-2018-021862
Open access 
data before surgery (preoperative), and 4–9 days, 6 and 
12 weeks after surgery (postoperative). Other parameters 
of interest will include quality of life, hip/knee pain, hip/
knee symptoms, psychological status and quality of sleep 
assessed by validated standardised measures.
The development of a comparable measure of patient 
function and mobility will be informed by the quantita-
tive and qualitative strands of the project. To understand 
whether living with the system is feasible and acceptable 
for patients undergoing surgery, and to address the factors 
that facilitate or hinder installation will be informed by 
the qualitative interviews.
recruitment process
Identification of patients
The clinical care team will identify potential participants 
who are eligible for the study. Patients will be approached 
consecutively and mailed a study information pack (letter 
of invitation, an information booklet, a reply slip and 
a FREEPOST addressed envelope). The information 
booklet will describe the purpose and aims of the study 
stating that they should return the reply slip indicating 
whether they are interested in taking part. If no response 
is received within 7 days, the clinical care team will send 
out a single reminder and information pack (supporting 
document 2). To track those that do not reply to the 
reminder and to provide statistics on the non-responders, 
the clinical care team will record anonymised data on age 
and gender for all patients sent a study information pack.
Enrolment
After an expression of interest is received, participants 
will be contacted by telephone and verbal agreement 
to participate confirmed and an appointment will be 
arranged to conduct Visit A (Introduction, Consent and 
Planning) by the study research team (study researcher 
and up to two SPHERE technicians) (see figure 2).
Participants will be informed that Visit B will be to install 
the SPHERE technology, the date and time of which will 
be arranged with the participant at Visit A.
Interviews
Interviews will be held at Visits C and D (see figure 2). 
Participants will be contacted by telephone and invited 
to participate in an interview. If the participant agrees to 
be interviewed, a suitable time and date will be arranged 
and a confirmation letter will be sent to the participant.
Household members
Consent will be taken from each household member 
during Visit A using a separate participant information 
sheet and consent form.
The recruitment and consent process are depicted in 
figure 3.
Recruitment period
Recruitment will run for approximately 8 months with an 
anticipated start date of September 2017.
data analysis
Data collection will take place throughout the 12-month 
study duration (see table 1). Data from the PROMs 
questionnaires will be entered onto a secure database. 
The SPHERE system will provide continuous data on 
the normal activities and movements of the participants 
within their home.
The study researcher and study statistician will work 
collaboratively with the clinicians and the SPHERE engi-
neering team to determine how the continuous SPHERE 
data collected from wearable wrist monitors, environment 
sensors and motion analysis (silhouette movements) 
can be transformed into various summary variables (eg, 
peak activity level, disruption of sleep time points). This 
will allow us to ascertain the extent to which these data 
correlate with the data provided by PROMs at relevant 
time points. Descriptive summary statistics (mean (SD), 
number (%), correlation) and statistical techniques 
(regression modelling) will be used to compare the data 
sets from the PROMs and SPHERE sensor system and 
report any associations. Determining predictive analytics 
for enhancing clinical decision support will subsequently 
form the latter phase of data analysis.
Interviews will be audio-recorded on a digital encrypted 
recording device, transcribed, anonymised and imported 
into qualitative software package QSR NVivo, v.11. Data 
will be analysed thematically, involving inductive coding 
and categorisation.33 A sample of approximately 20% of 
the transcripts will be double-coded by another member 
of the research team.
study limitations
The present study sample is small and the patients drawn 
from a relatively narrow age range, which limits gener-
alisability to patient populations in other settings. The 
nature of the research is exploratory. Deploying this tech-
nology as patients undergo surgery has implications on 
participant burden and may challenge recruitment. A key 
focus of the present study will be to address and consider 
such challenges, barriers and levers in conducting this 
research study within NHS ethical and governance frame-
works. The feasibility nature of the present study means 
that cost-effectiveness of the system will not presently 
be explored, but forms part of our wider programme of 
future research.
data integration
Owing to the mixed methodology design, the qualitative 
and quantitative components will be analysed separately 
but concurrently. This is the method of choice when anal-
ysis of one strand is necessary to inform the conduct of 
the next.19 Inferences will be drawn from both strands 
and across strands. These meta-inferences will be used 
to draw conclusions. Figure 1 outlines the steps for data 
analysis and integration.
data storage and sharing
The day-to-day management of the study and study 
data will be co-ordinated by the study researcher in the 
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Musculoskeletal Research Unit. Periodically, data will 
undergo additional checks to ensure consistency between 
data submitted on Case Report Forms (CRFs). The study 
sponsor will monitor the study, and this will include 
reviewing the Site File and patient medical records.
Anonymised data will be securely stored within the 
University of Bristol and shared according to University 
of Bristol procedures and guidelines.
Data procedures will be in keeping with the stipula-
tions in the General Data Protection Regulation. In line 
Figure 3 Overview of analysis and products of different strands in a concurrent design. SPHERE, Sensor Platform of 
Healthcare in a Residential Environment.
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with NIHR guidance, which encourages the sharing of 
anonymised datasets (for further information, please 
see http://www. journalslibrary. nihr. ac. uk/ replace/ 
report- preparation/ publication- ethics/3), we will be 
seeking consent from patients for their data to be shared 
anonymously with other researchers.
Confidentiality
All participants will be assured of the confidentiality of 
the data collected, but will be asked during the consent 
process for their permission to publish anonymised quota-
tions from the study. Participant paperwork, including 
consent forms and reply slips, will be maintained in a 
locked filing cabinet in the University of Bristol’s  Muscu-
loskeletal Research Unit, which is a secure unit with 
card-controlled access.
Patient and public involvement
Patient Experience Partnership in Research (PEP-R)
This study was developed in collaboration with the Univer-
sity of Bristol’s Musculoskeletal Research Unit’s patient 
involvement groups, Patient Experience Partnership in 
Research (PEP-R).34 PEP-R comprises nine patients with 
musculoskeletal conditions, most of whom have had joint 
replacements, all of whom have had experiences of long-
term pain, some after knee replacement.
The group is supported by the Research Unit’s experi-
enced Patient and Public Involvement co-ordinator (AB). 
We also consult regularly with SPHERE’s Public Engage-
ment Associate to discuss the design of materials and any 
other relevant documentation (eg, patient information 
leaflet, use of SPHERE sensor system images and inter-
view topic guide). Towards the end of the study, both 
groups will also be consulted to discuss anonymised find-
ings and dissemination strategies.
Publication policy
All collaborators will take an active part in the preparing 
and reviewing of all manuscripts and reports generated 
during or because of this study. All publications will accord 
with revised Open Access policy in the Research Coun-
cils UK guidance (http://www. rcuk. ac. uk/ research/ 
openaccess/).
dissemination policy
In addition to provision of annual and final reports, as 
well as presentations at scientific meetings and publica-
tion of findings in scientific literature, all participants 
in the study who want it will be sent a summary of the 
final results of the study. A copy of any related journal 
articles will also be available on request from the sponsor. 
Depending on the final findings of the study, the investi-
gators/collaborators may also seek further dissemination 
to both potential service users and professionals.
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